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Background: Multiple sclerosis (MS) is the most common autoimmune disorder of the central nervous system with profound effects on 
patients’ independence and self-efficacy. Then, it is still questionable whether self-management programs in patients with MS affect the 
patients’ self-efficacy.
Objectives: The present study aimed to investigate the effect of a self-management program plus regular follow-up on self-efficacy in 
patients with MS.
Patients and Methods: A quasi-experimental study was performed on 80 patients with relapsing remitting MS who were randomly 
allocated to an intervention (n = 40) and a control group (n = 40). The MS self-efficacy scale was completed before and after the 
intervention. The intervention group was divided into four small subgroups of ten. Then, each subgroup was invited to participate in four 
training sessions about self-management. During the two months after the self-management sessions, a weekly telephone follow-up was 
conducted for each patient in the intervention group. The control group did not receive any intervention other than routine care. Data 
were analyzed using SPSS 11.5. Descriptive statistics, Chi-square, and independent-samples t-testes were used to analyze the data.
Results: No significant difference in mean scores of baseline self-efficacy was found between the control (52.90 ± 8.03) and the intervention 
groups (54.90 ± 9.51) (P = 0.313). However, a significant difference was observed between the control (50.90 ± 5.71) and the intervention 
groups (59.80 ± 5.27) regarding mean scores of self-efficacy at the end of the study (P < 0.001).
Conclusions: Implementing the self-management program plus regular follow-up increased the perception of self-efficacy in patients 
with MS. Similar self-management programs are recommended to be integrated in the regular caring of patients with MS.
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1. Background
Multiple sclerosis (MS) is the most common autoim-
mune disorder of the central nervous system (1). In 2010, 
the number of people with MS was globally two million 
to 2.5 million (approximately 30 per 100000 persons), 
with rates varying widely in different regions (2). Of the 
100000 people with MS in the United Kingdom, about 
85% are first diagnosed with relapsing remitting MS 
(RRMS) (3). In Iran, the prevalence ranged from 5.3 to 
74.28 per 100000 persons in different regions, with the 
higher prevalence among females and female to male ra-
tio ranging from 1.8 to 3.6. The most prevalent subtype of 
MS is the RRMS (4).
According to the nature of the disease and its long-term 
complications, multidisciplinary services are needed. In 
the meantime, nurses have the key position in interact-
ing with patients and their families (5). Therefore, nurses 
should consider programs to empower patients in select-
ing appropriate healthy behaviors (6). Self-management 
programs are among the health promotion strategies fre-
quently used in patients with different chronic disorders 
such as MS (7).
A self-management program is a set of regular activities 
to help patients with a chronic disease to actively partici-
pate in controlling the factors affecting the disease process, 
symptom self-monitoring, and making appropriate deci-
sions to manage the disease process and its complications 
(8-11). It has been shown that self-management programs 
were successful in several chronic diseases and not only 
improved the patients level of perceived health, but also 
helped them in pain management, reducing the depres-
sion symptoms, and timely referring to the primary phy-
sician (8, 12). However, there is a gap in knowledge about 
application of self-management on patient’s self-efficacy 
in progressive long-term conditions (13). Jongen et al. have 
reported that some patients with RRMS are not interested 
in being engaged in self-management programs. They at-
tributed the problem to the lack of perceived self-efficacy 
in disease management. Hence, they suggested that self-
management programs should focus on improving the 
patients’ perception of self-efficacy and self-control (14).
Self-efficacy has been defined as the “belief in one’s 
capabilities to organize and execute the course of ac-
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tion required to produce given attainments (15).” It has 
been identified as a strong predictor of health status and 
health promotion behaviors in patients with MS (16, 17). 
Due to its nature and long-term course, MS has negative 
effects on patients’ self-efficacy (15, 17). Then, it is still 
questionable whether self-management programs in pa-
tients with MS affect the patients’ self-efficacy.
2. Objectives
The present study aimed to investigate the effect of a 
self-management program plus regular follow-up on self-
efficacy in patients with MS.
3. Patients and Methods
3.1. Study Design and Participants
A quasi-experimental study (pretest-posttest study, 
with control group) was performed on 80 patients with 
RRMS who were a member of the MS Society of Urmia. 
The study was conducted from December to March 2014. 
Sample size was calculated using the results of a previous 
study conducted by Kafami et al. in which S1, S2, μ1, and 
μ2 were respectively equal to 1.32, 1.24, 18.17, and 16.95 (18). 
Then, with a type I error of 0.05 and a power of 0.80, the 
sample size was estimated at 35 patients for each group. 
However, we recruited 40 patients with inclusion criteria 
in each group to compensate for the possible attritions. 
A random number table was used to assign the patients 
into intervention and control groups using a simple ran-
dom sampling method (Figure 1).
Inclusion criteria were being 18 to 60 years old, literate, 
willingness to participate in the study, ability to make 
phone calls and not having severe physical or psycholog-
ic comorbidities, problems in communication (i.e. visual 
or auditory loss). Patients with a relapse of the disease, 
those who used opiates during the study, and patients 
who decided to leave the study were excluded.
3.2. Instruments
A three-part instrument was used including a socio-
demographic questionnaire, the multiple sclerosis self-ef-
ficacy scale (MSSE), and a need assessment checklist. The 
first part consisted of 15 questions about the patients’ so-
cio-demographic characteristics including the patient’s 
gender, age, marital status, number of children, having 
insurance, employment status, type of residency, edu-
cation level, disease duration, and the interval between 
visits. The second part of the instrument, i.e. MSSE, con-
sists of 14 questions in four dimensions of independence, 
control of worry and anxiety, personal control, and social 
self-esteem. All items of the MSSE are responded on a six-
point Likert scale, ranging from one (strongly disagree) 
through six (strongly agree). The total score will be be-
tween 14 and 84 with a higher score indicating a higher 
level of self-efficacy.
Two experienced Iranian health professionals, bilingual 
in Farsi and English languages, independently translated 
the English language version of the MSSE into Farsi lan-
guage. Then, research team produced the consolidated 
forward version. Afterward, another bilingual person 
who did not have knowledge about the instrument per-
formed backward translation; the results were consistent 
with the original version.
The third part of the instrument was a need assessment 
checklist. This checklist was designed by the research 
team through literature review and was consisted of 21 
yes/no items on patients' needs. The content validity of 
MSSE and the checklist was confirmed by 13 faculty mem-
bers in Urmia University of Medical Sciences and Urmia 
Azad University of Medical Sciences. To examine the reli-
ability of the instrument and before the main study, ten 
patients with MS, who were not part of the study sample, 
responded the instrument at two times with a two-week 
interval. Then the reliability coefficient was calculated (r 
= 0.74 for the MSSE and r = 0.82 for the need assessment 
checklist).
3.3. Procedures
After obtaining informed consent for participation, the 
patient was asked to answer the socio-demographic ques-
tionnaire and the MSSE scale. All questionnaires were 
completed through individual interviews in a private 
room in the MS Society of Urmia. A trained interviewer 
who was blind to the patients’ groups conducted all in-
terviews. An interviewer asked the questions in a simple 
and clear way and entered the participants' answers into 
the study instrument. Additionally, patients in the inter-
vention group answered to the need assessment check-
list at this time.
Before starting self-management program, the inter-
vention group was divided into four small subgroups 
of ten. Then, each subgroup was invited to participate 
in four training sessions of self-management. Every ses-
sion lasted about two hours and was held in the morn-
ing or evening according to the patients free times. Three 
subgroups participated in the morning sessions and one 
subgroup in the evening because of being employed or 
being engaged in housekeeping activities. At the end of 
the fourth session, all patients in the intervention group 
were provided a self-management booklet including the 
contents of the training sessions. The content validity of 
the booklet was confirmed by nine faculty members in 
Nursing School of Urmia University of Medical Sciences. 
Finally, a total of 16 training sessions were held. All train-
ing sessions were facilitated by both authors. The overall 
content of the training sessions are listed in Table 1.
During the two months after the self-management ses-
sions, a weekly telephone follow-up was conducted for 
each patient in the intervention group. Each telephone 
follow-up lasted at least ten minutes or more based on 
patients’ needs. All follow-up contacts were conducted by 
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the second author and contained verbal reinforcements 
of the self-management sessions as well as answering the 
patients’ questions. Moreover, the researcher checked 
the patients’ adherence to the self-management program 
through questions about problem solving, decision mak-
ing, and changes in life style.
To prevent the exchange of information between the 
control group and the intervention group, the research-
ers collaborated with the MS clinic authorities to make 
some changes in the patients’ schedules to invite pa-
tients in the control and intervention groups in differ-
ent days. The control group did not receive any inter-
vention other than routine care. However, at the end of 
the study, the educational booklets were also provided 
to patients in this group to comply with the ethical 
standards. Once again, after two months, all patients 
in the control group and the intervention group were 
individually interviewed to answer the MSSE scale. All 
interviews were conducted by the same interviewer, at 
the MS Society of Urmia.
Table 1.  Curriculum for Training Sessions of Self-Management Program
Session Content of Each Session
Session 1 Discussion about the basic information: the nature of MS; routinely used medications; diet in MS; physical activity; 
stress and anxiety management; skills for using health resources; methods of therapeutic communication between 
patient and healthcare team
Session 2 Discussions, questions, and answers on "role management": maintenance of proper health behaviors; changes in life 
roles; problem solving skills; decision making skills; keeping independence through the course of the disease
Session 3 Discussions on "emotional management"; Question and answer on emotions such as fear, frustration, and depression 
and their appropriate management strategies; Patient's perspective for the future
Session 4 Scenario session: Putting the patients in situations similar to what happens in their daily life; Making a proper deci-
sion; How to became prepare for the daily hassles and daily living activities; Discussions and question and answer on 
using the lessons learned in the self-management sessions
 
          Assessed for eligibility  (n = 80) 
Randomized (n = 80) 
Excluded (n = 0) , Not meeting inclusion criteria (n = 0), 
Declined to participate (n = 0), Other reasons (n = 0)  
Allocated to intervention group (n = 40)  
Enrollment 
Lost to follow -up (n=0)  
Analyzed (n= 40)  
Excluded from analysis (n=0)  
Allocated to control group (n = 40)  
Lost to follow -up (n=0)  
Analyzed (n= 30) 




Figure 1. The Sampling Framework of the Study
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3.4. Ethical Considerations
The study was approved by the Research Deputy and 
the Research Ethics Committee of Urmia University of 
Medical Sciences. The researcher explained the objectives 
to the patients and all participants signed a written in-
formed consent before participation. The questionnaires 
were anonymous and all of the participants were assured 
about the confidentiality of their personal information. 
The participants were free to leave the study at any time. 
The researchers observed all ethical issues in accordance 
with the latest version of Helsinki declaration.
3.5. Data Analysis
Data analysis was performed using the SPSS 11.5 (SPSS Inc, 
Chicago, Illinois, the United States). The normality of the 
data distribution was assessed using Kolmogorov-Smirnov 
test. Mean score and standard deviation were calculated. 
Chi-square test was used to compare nominal variables 
between the two groups. Student's t-test was also used to 
compare the statistical difference between the mean dif-
ferences of self-efficacy and its dimensions in the two 
groups. P < 0.05 were considered statistically significant.
4. Results 
 Table 2 presents the socio-demographic characteris-
tics of the two study groups. No significant differences 
were observed between the intervention and the control 
group in terms of age, gender, marital status, number of 
children, having insurance, education level, type of resi-
dency, employment status, duration of the disease, and 
intervals between visits.
Table 2.  Comparison of Demographic Characteristics of the Control and the Intervention Groups a
Variable Group Chi-square
Control Intervention
Gender χ2 = 0.549, P = 0.459
Female 30 (75) 27 (67.5)
Male 10 (25) 13 (32.5)
Marital status χ 2 = 0.201, P = 0.654
Single 20 (50) 18 (45)
Married 20 (50) 22 (55)
Number of children χ 2 = 1.853, P = 0.396
0 2 (9.1) 5 (20.8)
1 8 (36.4) 10 (41.7)
≥2 12 (54.5) 9 (37.5)
Having an insurance χ 2 = 0.157, P = 0.692
Yes 37 (92.5) 36 (90.0)
No 3 (7.5) 4 (10.0)
Education level χ 2 = 0.547, P = 0.761
Primary and intermediate School 10 (25.0) 12 (30.0)
High School 15 (37.5) 12 (30.0)
University 15 (37.5) 16 (40.0)
Type of residence χ 2 = 3.480, P = 0.176
Rental 4 (10.0) 6 (15.0)
Owner 29 (72.5) 21 (52.5)
Other 7 (17.5) 13 (32.5)
Employment status χ 2 = 1.303, P = 0.728
Unemployed 16 (40.0) 15 (37.5)
Housewife 11 (27.5) 13 (32.5)
Employee 7 (17.5) 4 (10.0)
Disabled 6 (15.0) 8 (20.0)
Age, y 30.25 ± 7.25 29.87 ± 8.07 P = 0.828 b
Disease duration, y 3.40 ± 2.79 3.82 ± 3.21 P = 0.530 b
Interval between the visits, mo 2.57 ± 1.10 2.15 ± 0.86 P = 0.059 b
a  Data are presented as No. (%) or mean ± SD.
b Result of independent-samples t-test.
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Table 3. Self-Efficacy Mean Scores of the Intervention and Control Groups Before and After Implementing the Self-Management Pro-
gram a
Self-Efficacy Group 95% CI P value
Control Intervention
Before intervention 52.90 ± 8.037 54.90 ± 9.518 -5.92 to 1.92 P = 0.313
After intervention 50.90 ± 5.714 59.80 ± 5.273 -11.34 to -6.45 P < 0.001
a  Data are presented as mean ± SD.
Table 4. Mean Scores of Self-Efficacy Dimensions of the Intervention and Control Groups Before and After Implementing the Self-
Management Program a
Dimensions of Self-Efficacy 
(Lowest and Highest Scores)
Group 95% CI P value
Control Intervention
Independence (score: 6-30)
Before 18.92 ± 4.06 20.75 ± 4.53 -3.71 to 0.91 P = 0.062
After 17.50 ± 3.17 20.85 ± 2.79 -4.68 to -2.01 P < 0.001
Control of anxiety and worry 
(score: 6-24)
Before 14.40 ± 2.98 14.62 ± 4.62 -1.86 to 1.41 P = 0.786
After 14.70 ± 2.86 17.70 ± 1.92 -2.62 to -0.87 P < 0.001
Personal control (score: 6-18)
Before 12.45 ± 2.45 12.50 ± 2.69 -1.19 to 1.09 P = 0.931
After 12.10 ± 1.86 13.85 ± 2.06 -2.62 to -0.87 P < 0.001
Social self-esteem (score: 6-12)
Before 7.12 ± 1.57 7.02 ± 2.11 -0.73 to 0.93 P = 471
After 6.60 ± 1.62 7.40 ± 1.31 -1.45 to -0.14 P = 0.061
a Data in table are presented as mean ± SD
Independent sample t-test showed no significant differ-
ence in mean scores of baseline self-efficacy between the 
control group (52.90 ± 8.03) and the intervention group 
(54.90 ± 9.51) (P = 0.313). However, a significant difference 
in self-efficacy mean scores was observed between the 
control group (50.90 ± 5.714) and the intervention group 
(59.80 ± 5.27) at the end of the study (P < 0.001) (Table 3).
Using the independent-samples t-test, no significant dif-
ferences in mean scores of self-efficacy dimensions were 
found between the two groups before the intervention. 
However, at the end of the study, the mean scores of the 
intervention group increased in all self-efficacy dimen-
sions. Therefore, significant differences were observed 
between the two groups regarding mean scores of all 
self-efficacy dimensions, except for the social self-esteem 
dimension (Table 4).
5. Discussion
The results of this study showed that the mean of self-
efficacy score was significantly improved in the inter-
vention group after implementing a self-management 
program. It may be concluded that the self-management 
program could increase the level of self-efficacy in pa-
tients with MS. This finding is consistent with results of 
Kafami et al. who studied the effect of a self-management 
program on health perception in patients with MS (18). 
Some studies have investigated and reported the positive 
effects of nurse-led self-management trainings on self-ef-
ficacy of patients with cardiovascular disorders (19) and 
hypertension (20). On the other hand, Haas et al. studied 
the effect of a self-management program on chronic low 
back pain in a sample of elderly and reported that the in-
tervention had no significant effect on the patients’ self-
efficacy (21). Self-efficacy is a subjective multidimensional 
perception; therefore, several factors such as the patients’ 
personality trait and self-esteem as well as the contextual 
factors such as the level of available social support might 
affect it. Perhaps the follow-up added to the present study 
reinforced the effects of the main self-management pro-
gram through instilling a sense of social support. How-
ever, patients with MS are usually uncertain about their 
ability for self-management, which consequently makes 
them more dependent to their family or the healthcare 
team. Hence, it is essential to not only train them on self-
management but also inspire them a sense of ability and 
self-control. Then, their level of uncertainty would be re-
duced and their motive and sense of self-efficacy would 
be enhanced.
The current study showed that the self-management 
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program could significantly increase the mean score of 
the intervention group in the domain of independence. 
This finding was consistent with results of Garrett and 
Bluml who implemented a self-management program in 
patients with diabetes and reported that after the inter-
vention, patients were able to control their blood sugar 
and maintain it at an acceptable level (22). Patients with 
MS have several problems such as weakness, abnormal 
gait, and ataxia that bring them difficulties in functional 
roles and make them dependent on their families and 
caregivers. However, as revealed in the present study, self-
management programs might help them use their abili-
ties in a better way and become more independent.
The implemented self-management program and fol-
low-up in this study could significantly increase the mean 
score of the intervention group in the domain of "control 
of worry and anxiety." This improvement might be attrib-
uted to the improvement in patients’ emotional respons-
es to the life conditions. An improvement in emotional 
condition might result in an improvement in overall per-
ception of self-efficacy. Emotional management was part 
of the self-management program and the learned con-
tent might help the patients in the intervention group to 
select more appropriate strategies in response to stress-
ful and anxious situations. This is consistent with results 
of Thomas et al. and Stuifbergen et al. who reported that 
self-management programs have beneficial effects on pa-
tients’ health perceptions and anxiety levels (23, 24).
The implemented self-management program and 
follow-up in the current study could increase the mean 
score of the "personal control" dimension in interven-
tion group. It seems that a sense of personal control is in 
mutual relationship with improvement in independence 
and control of anxiety and worry. Bishop and Frain have 
also reported that improvement in self-management 
might positively affect patients’ self-control and quality 
of life (25). Moreover, Stanton et al. have reported that in-
dividuals with a feeling of being self-controlled feel high-
er levels of self-efficacy (26). It seems that as Schore and 
Schore have reported, a feeling of being self-controlled 
helps the individuals to use their internal and external 
resources more efficiently in dealing with the demands 
of the disease (27).
The intervention did not significantly affect the dimen-
sion of ‘social self-esteem’. The majority of people with 
MS are young and the aftermaths of the disease signifi-
cantly increase their dependence on others. Social self-
esteem is socially dependent. Any improvement is this 
domain would be gradual and is dependent not only to 
the patient’s functional abilities but also to the degree 
of available social supports. Moreover, changes in social 
self-esteems will happen gradually and need a longer 
time to become evident. Therefore, long-term follow-up 
is needed to assess the changes in this domain.
Results of this study showed that implementing a self-
management program and regular follow-up would 
increase the perception of self-efficacy in patients with 
MS. Considering the beneficial effects of this self-man-
agement program, integrating similar self-management 
programs in the regular caring of patients with MS are 
recommended.
This study was conducted on a small number of pa-
tients. Moreover, the duration of follow-up and the inter-
val between intervention and outcome assessment were 
short. Hence, replication of the same study with larger 
sample size and longer follow-up and longer interval be-
tween the intervention and outcome assessment is sug-
gested.
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